PPTA's 2012 Plasma Protein Forum

Myrl Weinberg, President of the National Health Council delivered a dynamic keynote assessing risk and benefit from a patient perspective.

The Honorable Michael C. Burgess, (R-TX), outlined health policy perspectives from the U.S. Congress. Other presentations and panels addressed the impact of the Affordable Health Care Act on the States, the cost effectiveness of plasma protein therapies.

PPTA staff welcomes attendees to the Forum

Kym Kilbourne, Congressman Michael Burgess and
Jan M. Bult

Josh Penrod presents Rudolf Meixner,
President, Europlasma GmbH with IQPP certification -- the first in the Czech Republic

Ileana Carlisle delivers a testament to industry in final act as Source Board Chair

Exhibitors demonstrate the latest industry innovations

Attendees enjoy informal opportunities to connect

Steve Pettaway received the Otto Schwarz Award
for leadership in the industry and scientific fields of expertise

 Otto Schwarz Award accepted by Christopher Healey, Grifols